Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Research & Development: 2011-2024

Historic Research & Development for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to $34.4 million.

  • Abeona Therapeutics' Research & Development fell 52.85% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year decrease of 11.15%. This contributed to the annual value of $34.4 million for FY2024, which is 10.51% up from last year.
  • As of FY2024, Abeona Therapeutics' Research & Development stood at $34.4 million, which was up 10.51% from $31.1 million recorded in FY2023.
  • Abeona Therapeutics' Research & Development's 5-year high stood at $38.7 million during FY2021, with a 5-year trough of $29.0 million in FY2022.
  • Over the past 3 years, Abeona Therapeutics' median Research & Development value was $31.1 million (recorded in 2023), while the average stood at $31.5 million.
  • In the last 5 years, Abeona Therapeutics' Research & Development rose by 28.49% in 2021 and then declined by 25.21% in 2022.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Research & Development stood at $30.1 million in 2020, then increased by 28.49% to $38.7 million in 2021, then fell by 25.21% to $29.0 million in 2022, then rose by 7.34% to $31.1 million in 2023, then increased by 10.51% to $34.4 million in 2024.